Entrada Therapeutics Inc (TRDA) — Cash Flow Quality Index
Entrada Therapeutics Inc (TRDA) has a Cash Flow Quality Index of -27.94x as of December 2024. Operating cash flow of $-31.61 Million is below net income of $1.13 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore TRDA debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Entrada Therapeutics Inc Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Entrada Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Entrada Therapeutics Inc.
Annual Cash Flow Quality Index for Entrada Therapeutics Inc (2024–2024)
Year-by-year earnings quality comparison for Entrada Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.63x | $-41.56 Million | $65.63 Million | — |